RESUMEN
In order to obtain an adsorption tendency of H2, CO and CO2 molecules on (TiO2)n n = 15-20 clusters, DFT calculations were carried out to evaluate the interaction among these systems. The (TiO2)19 cluster emerges as the best candidate to storage these chemical species. Then, two adsorption sites were considered to attach these molecules onto (TiO2)19 cluster: through of surface formed by i) titanium and ii) oxygen atoms, respectively. The adsorption energy values are more favored for case 1 than the case 2, due to short distances between titanium atom and these chemical species. In this sense, the larger values of chemisorption are related to great decreasing of values of vibrational modes for gases isolated respect to those bonded to bare cluster. In general, the values of electronic gap do not suffer drastic changes, however the HOMO iso-surfaces are displayed in different way for both cases, and LUMO is located at center of cluster for the whole set of systems analyzed in this study. The electronic transference occurs from chemical species toward atoms at adsorption site, in all systems. These results reveal that this (TiO2)19 cluster is good candidate to storage or sense different kind of gases; thereby, this system can be used as a hydrogen storage device for energy green applications.
RESUMEN
INTRODUCTION AND AIMS: Orthotopic liver transplant (OLT) is the definitive treatment of most types of liver failure. Transjugular intrahepatic portosystemic shunt (TIPS) and portocaval shunt placement procedures reduce the systemic vascular complications of portal hypertension. TIPS placement remains a "bridge" therapy that enables treatment of refractory symptoms until transplantation becomes available. The aim of the present study was to describe the operative impact of TIPS prior to OLT. MATERIALS AND METHODS: A retrospective review was conducted on patients that underwent liver transplant at the Hospital San José within the timeframe of 1999 and February 2020. RESULTS: We reviewed a total of 92 patients with OLT. Sixty-six patients were male and 26 were female, with a mean age of 52 years. Nine (9.8%) of the 92 patients had a TIPS, before the OLT. Preoperative Child-Pugh class, MELD score, and sodium and platelet levels were similar between groups. We found no difference in the means of intensive care unit stay, operative time, or blood transfusions for liver transplant, with or without previous TIPS. There was no significant difference between groups regarding vascular and biliary complication rates or the need for early intervention. The overall one-year mortality rate in the TIPS group was 11%. CONCLUSIONS: TIPS is an appropriate therapeutic bridge towards liver transplant. We found no greater operative or postoperative complications in patients with TIPS before OLT, when compared with OLT patients without TIPS. The need for transfusion, operative time, and ICU stay were similar in both groups.
RESUMEN
INTRODUCCIÓN: El manejo de la enfermedad de Parkinson en la mujer en edad fértil nos plantea como principal reto el manejo de la enfermedad y los fármacos durante el embarazo y lactancia. El aumento de la edad gestacional de la mujer hace más probable que la incidencia de embarazos pueda incrementarse. OBJETIVO: Definir las características clínicas y los factores que condicionan la vida de la mujer en edad fértil con enfermedad de Parkinson y definir una guía de actuación y manejo del embarazo en estas pacientes. RESULTADOS: Este documento de consenso se ha realizado mediante una búsqueda bibliográfica exhaustiva y discusión de los contenidos realizados por un grupo de expertos en trastornos del movimiento de la Sociedad Española de Neurología. CONCLUSIONES: La enfermedad de Parkinson afecta a todos los aspectos relacionados con la salud sexual y reproductiva de la mujer en edad fértil. Se debe planificar el embarazo en las mujeres con enfermedad de Parkinson para minimizar los riesgos teratogénicos sobre el feto. Se recomienda un abordaje multidisciplinar de estas pacientes para tener en cuenta todos los aspectos implicados
INTRODUCTION: The main challenge of Parkinson's disease in women of childbearing age is managing symptoms and drugs during pregnancy and breastfeeding. The increase in the age at which women are having children makes it likely that these pregnancies will become more common in future. OBJECTIVES: This study aims to define the clinical characteristics of women of childbearing age with Parkinson's disease and the factors affecting their lives, and to establish a series of guidelines for managing pregnancy in these patients. RESULTS: This consensus document was developed through an exhaustive literature search and a discussion of the available evidence by a group of movement disorder experts from the Spanish Society of Neurology. CONCLUSIONS: Parkinson's disease affects all aspects of sexual and reproductive health in women of childbearing age. Pregnancy should be well planned to minimise teratogenic risk. A multidisciplinary approach should be adopted in the management of these patients in order to take all relevant considerations into account
Asunto(s)
Humanos , Femenino , Embarazo , Consenso , Guías de Práctica Clínica como Asunto , Enfermedad de Parkinson/terapia , Trastornos del Movimiento/terapia , Complicaciones del Embarazo/terapia , Enfermedad de Parkinson/fisiopatología , Trastornos del Movimiento/fisiopatología , Complicaciones del Embarazo/fisiopatología , Factores de Riesgo , Antiparkinsonianos/uso terapéutico , Lactancia Materna , EspañaRESUMEN
INTRODUCCIÓN: Muchas enfermedades que cursan con trastornos del movimiento hipercinético comienzan o afectan a mujeres en edad fértil. Es importante conocer los riesgos que tienen las mujeres con estas enfermedades durante el embarazo, así como los posibles efectos de los tratamientos sobre el feto. OBJETIVOS: Definir las características clínicas y los factores que condicionan la vida de la mujer en edad fértil con distonía, corea, síndrome de Tourette, temblor y síndrome de piernas inquietas. Definir una guía de actuación y manejo del embarazo y lactancia en las pacientes con esta enfermedad. DESARROLLO: Este documento de consenso se ha realizado mediante una búsqueda bibliográfica exhaustiva y discusión de los contenidos llevadas a cabo por un Grupo de Expertos en Trastornos del Movimiento de la Sociedad Española de Neurología (SEN). CONCLUSIONES: En todas las mujeres que padecen o comienzan con trastornos del movimiento hipercinéticos se debe valorar el riesgo-beneficio de los tratamientos, reducir al máximo la dosis eficaz o administrarlo de forma puntual en los casos en que sea posible. En aquellas enfermedades de causa hereditaria es importante un consejo genético para las familias. Es importante reconocer los trastornos del movimiento desencadenados durante el embarazo como determinadas coreas y síndrome de piernas inquietas
INTRODUCTION: Many diseases associated with hyperkinetic movement disorders manifest in women of childbearing age. It is important to understand the risks of these diseases during pregnancy, and the potential risks of treatment for the fetus. OBJECTIVES: This study aims to define the clinical characteristics and the factors affecting the lives of women of childbearing age with dystonia, chorea, Tourette syndrome, tremor, and restless legs syndrome, and to establish guidelines for management of pregnancy and breastfeeding in these patients. RESULTS: This consensus document was developed through an exhaustive literature search and a discussion of the content by a group of movement disorder experts from the Spanish Society of Neurology. CONCLUSIONS: We must evaluate the risks and benefits of treatment in all women with hyperkinetic movement disorders, whether pre-existing or with onset during pregnancy, and aim to reduce effective doses as much as possible or to administer drugs only when necessary. In hereditary diseases, families should be offered genetic counselling. It is important to recognise movement disorders triggered during pregnancy, such as certain types of chorea and restless legs syndrome
Asunto(s)
Humanos , Femenino , Embarazo , Consenso , Guías de Práctica Clínica como Asunto , Enfermedad de Parkinson/terapia , Trastornos del Movimiento/terapia , Complicaciones del Embarazo/terapia , Enfermedad de Parkinson/fisiopatología , Trastornos del Movimiento/fisiopatología , Complicaciones del Embarazo/fisiopatología , Factores de Riesgo , Antiparkinsonianos/uso terapéutico , Lactancia Materna , Asesoramiento Genético , Estimulación Encefálica Profunda/métodos , EspañaRESUMEN
INTRODUCTION: The main challenge of Parkinson's disease in women of childbearing age is managing symptoms and drugs during pregnancy and breastfeeding. The increase in the age at which women are having children makes it likely that these pregnancies will become more common in future. OBJECTIVES: This study aims to define the clinical characteristics of women of childbearing age with Parkinson's disease and the factors affecting their lives, and to establish a series of guidelines for managing pregnancy in these patients. RESULTS: This consensus document was developed through an exhaustive literature search and a discussion of the available evidence by a group of movement disorder experts from the Spanish Society of Neurology. CONCLUSIONS: Parkinson's disease affects all aspects of sexual and reproductive health in women of childbearing age. Pregnancy should be well planned to minimise teratogenic risk. A multidisciplinary approach should be adopted in the management of these patients in order to take all relevant considerations into account.
Asunto(s)
Enfermedad de Parkinson , Adolescente , Adulto , Consenso , Femenino , Humanos , Neurología , Enfermedad de Parkinson/tratamiento farmacológico , Adulto JovenRESUMEN
INTRODUCTION: Many diseases associated with hyperkinetic movement disorders manifest in women of childbearing age. It is important to understand the risks of these diseases during pregnancy, and the potential risks of treatment for the fetus. OBJECTIVES: This study aims to define the clinical characteristics and the factors affecting the lives of women of childbearing age with dystonia, chorea, Tourette syndrome, tremor, and restless legs syndrome, and to establish guidelines for management of pregnancy and breastfeeding in these patients. RESULTS: This consensus document was developed through an exhaustive literature search and a discussion of the content by a group of movement disorder experts from the Spanish Society of Neurology. CONCLUSIONS: We must evaluate the risks and benefits of treatment in all women with hyperkinetic movement disorders, whether pre-existing or with onset during pregnancy, and aim to reduce effective doses as much as possible or to administer drugs only when necessary. In hereditary diseases, families should be offered genetic counselling. It is important to recognise movement disorders triggered during pregnancy, such as certain types of chorea and restless legs syndrome.
Asunto(s)
Trastornos del Movimiento , Enfermedad de Parkinson , Adolescente , Adulto , Corea , Distonía , Femenino , Humanos , Trastornos del Movimiento/tratamiento farmacológico , Enfermedad de Parkinson/tratamiento farmacológico , Síndrome de las Piernas Inquietas/tratamiento farmacológico , Síndrome de Tourette , Adulto JovenRESUMEN
In this work, food-grade sunflower oil/W Pickering emulsions stabilized by xanthan gum-zein complex were developed. For this purpose, laser diffraction, rheological, multiple light scattering, confocal laser scanning microscopy (CLSM) and field emission scanning electron microscopy (FESEM) measurements were carried out. A response surface methodology was used to determine the optimized zein and oil concentration of the emulsion by using D4,3 and Turbiscan Stability Index (TSI) as objective functions to minimize. Subsequently, the optimized formulation with minimum D4,3 was selected and the biological macromolecule, advanced performance xanthan gum (APXG), was added. CLSM results of emulsions without gum showed the location of zein in the oil-water interface protecting droplets against coalescence as Pickering stabilizer. They also demonstrated that zein did not present important aggregation at the working pH. The addition of APXG changed the flow behaviour from Newtonian to shear thinning which fitted to the Cross model. This fact provoked the occurrence of viscoelastic properties and an increase in stability. FESEM results suggested the formation of a zein-gum complex, which forms a layer covering the droplets, protecting them against oxidation and physical destabilization. Therefore, this research supports the role of zein-APXG complex as a stabilizer of future emulsions.
Asunto(s)
Polisacáridos Bacterianos/química , Aceite de Girasol/química , Zeína/química , EmulsionesRESUMEN
OBJECTIVE: To determine 50:50% perceptibility threshold (PT) and 50:50% acceptability threshold (AT) for computer-simulated samples of human gingiva using CIEDE2000 and CIELAB color difference formulas. MATERIALS AND METHODS: Each of the 60 pairs of simulated human gingiva was displayed on a calibrated monitor, together with three pairs of upper central incisors of different lightness. The color of gingiva left and right from the midline was compared. A total of 30 observers (15 dentists, 15 laypersons) participated in the study. CIEDE2000 and CIELAB formulas were used to calculate the thresholds and a Takagi-Sugeno-Kang Fuzzy Approximation model was used as fitting procedure. Paired t-test (α = 0.05) was used in evaluation of statistical significance of differences. RESULTS: The PT and AT for CIEDE2000 and 95% confidence intervals were 1.1 [0.4, 1.7] and 2.8 [1.8, 4.0], respectively. Corresponding CIELAB values were 1.7 [0.2, 2.6] and 3.7 [2.1, 5.7]. Significant differences (P < .01) were recorded between PT and AT, between the corresponding threshold values in CIEDE2000 and CIELAB formulas as well as between dentists and laypersons. CONCLUSIONS: The difference between the perceptibility and acceptability threshold for gingiva was statistically significant in both CIEDE2000 and CIELAB. The same was true for differences between the corresponding thresholds using two color difference formulas, and between dentists and laypersons. Visual thresholds of human gingiva were not dependent upon lightness of adjacent teeth. Overall, CIEDE2000 color difference formula provided better fit than CIELAB formula in the evaluation of color difference thresholds of human gingiva. CLINICAL SIGNIFICANCE: The data on visual thresholds for healthy human gingiva can be used as quality control tool/guide for selection and evaluation of dental materials, interpretation of color-related findings in clinical dentistry and research, and for standardization in dentistry. It is of particular value that this study was designed based on in-vivo color evaluation of healthy keratinized gingiva of subjects of different ethnicities, age groups, and gender.
Asunto(s)
Percepción de Color , Encía , Color , Materiales Dentales , Odontología , HumanosRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Anciano , Isquemia/complicaciones , Isquemia/diagnóstico , Isquemia/cirugía , Aneurisma/complicaciones , Aneurisma/diagnóstico , Aneurisma/cirugía , Procedimientos Endovasculares/instrumentación , Procedimientos Endovasculares/métodos , Procedimientos Endovasculares , Norepinefrina/uso terapéutico , Stents Liberadores de Fármacos/psicología , Stents Liberadores de Fármacos , Paraplejía/complicaciones , Paraplejía/rehabilitación , Paraplejía/cirugía , PronósticoRESUMEN
BACKGROUND: Information is scarce regarding the impact of treatment on Health-Related Quality of Life (HRQL) of patients with Head and Neck (H&N) cancers. We assessed the effect of treatment on HRQL and its association with prognosis in H&N cancer. PATIENTS AND METHODS: Patients with H&N cancer in whom HRQL was assessed before and after treatment. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-H&N35 instruments were used. Association of changes in patients' HRQL after treatment with Loco-Regional Recurrence (LRR) and Overall Survival (OS) was investigated. RESULTS: One hundred sixty patients were included; scales of the baseline assessment of HRQL were moderately associated with LRR and OS, but the impact of treatment on most HRQL scales was strongly associated with OS. By multivariate analysis, baseline assessment of Global Health, Physical, HN Teeth, HN Dry mouth, and HN Cough scales, and impact of treatment on the Physical and Pain scales comprised independent variables associated with LRR. Male gender, positive lymph nodes, baseline assessment of Role, HN Pain, HN Cough, and impact of treatment on Emotion, Pain, Financial, HN Swallowing, HN Social contact, and the interaction of HN Pain-change in Pain scales were associated with OS. Both multivariate models were adjusted by the neoplasm's site of origin. CONCLUSION: Aside from well-known clinical-pathologic prognostic factors in H&N cancers, HRQL assessment, both prior to and after treatment, provides significant prognostic information and should be measured. Design of therapeutic clinical trials in patients with H&N cancers should consider these novel prognostic factors.
Asunto(s)
Neoplasias de Cabeza y Cuello/terapia , Calidad de Vida , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Neoplasias de Cabeza y Cuello/diagnóstico , Neoplasias de Cabeza y Cuello/mortalidad , Neoplasias de Cabeza y Cuello/psicología , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , PronósticoRESUMEN
Objetivo. Conocer el manejo de la hemostasia y la práctica transfusional entre los anestesiólogos españoles en el ámbito del trasplante hepático. Método. Se elaboró un cuestionario dirigido a los facultativos especialistas en anestesiología y reanimación de todos los centros que realizan trasplante hepático en España. Los datos requeridos hacían referencia a los 12 meses previos a su distribución, desde el 1 de enero al 31 de diciembre de 2011. Resultados. Se recogieron datos de los 24 centros. Solo el 46% respondieron disponer de protocolos o guías de actuación para el manejo de la hemostasia. El 83% de los centros respondieron conocer el porcentaje de pacientes transfundidos, pero solo el 57% conocía la media de hemoderivados. La mitad respondió estar nada satisfecho con el manejo realizado. La tromboelastometría fue utilizada como método adicional de monitorización en el preoperatorio solo en el 8% de los centros y en un tercio durante el intraoperatorio. El 46% de los centros realizó corrección preoperatoria de los déficits de coagulación basados en test convencionales. En cuanto al consumo de hemoderivados, en el 57% de los centros la media de transfusión de concentrados de hematíes fue ≤ 4. El consumo de plasma fresco congelado fue muy variable, mientras que en el 100% de los centros se consumieron menos de 4 pools de plaquetas por paciente. Conclusiones. Existe una amplia variabilidad en el manejo de la hemostasia y en la práctica transfusional entre los centros españoles. No existen guías de manejo perioperatorio o no son utilizadas ampliamente. Las medias de hemoderivados transfundidos siguen siendo elevadas. Se aprecia un descenso en los centros que utilizan los nuevos métodos de monitorización (AU)
Objective. To determine the management of haemostasis and transfusion practice in the field of liver transplantation in Spain. Methods. A questionnaire was developed for physicians in anaesthesiology of all centres performing liver transplantation in Spain. The information required made reference to the 12 months prior to its distribution, from January 1 to December 31, 2011. Results. Data were collected from 24 centres in which liver transplantation is performed in Spain. Only 46% reported that they had protocols or practice guidelines for the management of haemostasis, and 83% of hospitals responded that they knew the percentage of transfused patients, but only 57% knew the mean transfusion. Regarding the degree of satisfaction with the management of haemostasis/coagulation, 50% said they were not satisfied. Thromboelastometry was used as an additional method of preoperative monitoring in only 8% of the centres and intra-operatively in one-third. Less than half (46%) of the centres performed preoperative correction of coagulation deficits based on conventional tests. The mean number of packed red cells used was ≤ 4 in 57% of centres. Consumption of fresh frozen plasma was highly variable, while 100% of centres consumed less than 4 pools of platelets per patient. Conclusions. There is a wide variability in the management of haemostasis and transfusion practice among Spanish centres. There are no guidelines or they are not widely used. The mean use of transfused blood products remain high. There was a decrease in centres using new methods of monitoring (AU)
Asunto(s)
Humanos , Masculino , Femenino , Hemostasis Quirúrgica/métodos , Hemostasis Quirúrgica/enfermería , Trasplante de Hígado/educación , Trasplante de Hígado/ética , Enfermeras Anestesistas/educación , Reanimación Cardiopulmonar/métodos , España , Plasma Rico en Plaquetas/citología , Hemostasis Quirúrgica/normas , Hemostasis Quirúrgica , Trasplante de Hígado/métodos , Trasplante de Hígado/normas , Enfermeras Anestesistas/normas , Reanimación Cardiopulmonar/normas , Plasma Rico en Plaquetas/químicaRESUMEN
OBJECTIVE: To determine the management of haemostasis and transfusion practice in the field of liver transplantation in Spain. METHODS: A questionnaire was developed for physicians in anaesthesiology of all centres performing liver transplantation in Spain. The information required made reference to the 12 months prior to its distribution, from January 1 to December 31, 2011. RESULTS: Data were collected from 24 centres in which liver transplantation is performed in Spain. Only 46% reported that they had protocols or practice guidelines for the management of haemostasis, and 83% of hospitals responded that they knew the percentage of transfused patients, but only 57% knew the mean transfusion. Regarding the degree of satisfaction with the management of haemostasis/coagulation, 50% said they were not satisfied. Thromboelastometry was used as an additional method of preoperative monitoring in only 8% of the centres and intra-operatively in one-third. Less than half (46%) of the centres performed preoperative correction of coagulation deficits based on conventional tests. The mean number of packed red cells used was ≤4 in 57% of centres. Consumption of fresh frozen plasma was highly variable, while 100% of centres consumed less than 4 pools of platelets per patient. CONCLUSIONS: There is a wide variability in the management of haemostasis and transfusion practice among Spanish centres. There are no guidelines or they are not widely used. The mean use of transfused blood products remain high. There was a decrease in centres using new methods of monitoring.
Asunto(s)
Transfusión Sanguínea , Hemostasis , Humanos , Trasplante de Hígado , España , Encuestas y CuestionariosAsunto(s)
Aneurisma de la Aorta Torácica/cirugía , Complicaciones Posoperatorias/terapia , Isquemia de la Médula Espinal/etiología , Isquemia de la Médula Espinal/terapia , Anciano , Implantación de Prótesis Vascular , Procedimientos Endovasculares , Humanos , Masculino , Paraplejía/etiología , Paraplejía/terapia , Complicaciones Posoperatorias/diagnóstico por imagen , Isquemia de la Médula Espinal/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Niño , Manejo de la Vía Aérea/métodos , Cuidados Preoperatorios/métodos , Epiglotis/anatomía & histología , Boca/anatomía & histología , Hallazgos Incidentales , Adenoidectomía , Variación AnatómicaRESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Adulto , Analgesia Epidural/instrumentación , Analgesia Epidural/métodos , Trasplante de Riñón/métodos , Trasplante de Riñón/tendencias , Fentanilo/uso terapéutico , Intubación Intratraqueal/métodos , Catéteres Venosos Centrales , Analgesia Epidural/normas , Analgesia Epidural , Trasplante de Riñón/normas , Trasplante de Riñón , Respiración Artificial/métodos , Bupivacaína/uso terapéuticoRESUMEN
PURPOSE: The study's objective was to develop diagnostic predictive models using data from two commonly used [(123)I]FP-CIT SPECT assessment methods: region-of-interest (ROI) analysis and whole-brain voxel-based analysis. METHODS: We included retrospectively 80 patients with vascular parkinsonism (VP) and 164 patients with Parkinson's disease (PD) who underwent [(123)I]FP-CIT SPECT. Nuclear-medicine specialists evaluated the scans and calculated bilateral caudate and putamen [(123)I]FP-CIT uptake and asymmetry indices using BRASS software. Statistical parametric mapping (SPM) was used to compare the radioligand uptake between the two diseases at the voxel level. Quantitative data from these two methods, together with potential confounding factors for dopamine transporter availability (sex, age, disease duration and severity), were used to build predictive models following a tenfold cross-validation scheme. The performance of logistic regression (LR), linear discriminant analysis and support vector machine (SVM) algorithms for ROI data, and their penalized versions for SPM data (penalized LR, penalized discriminant analysis and SVM), were assessed. RESULTS: Significant differences were found in the ROI analysis after covariate correction between VP and PD patients in [(123)I]FP-CIT uptake in the more affected side of the putamen and the ipsilateral caudate. Age, disease duration and severity were also found to be informative in feeding the statistical model. SPM localized significant reductions in [(123)I]FP-CIT uptake in PD with respect to VP in two specular clusters comprising areas corresponding to the left and right striatum. The diagnostic predictive accuracy of the LR model using ROI data was 90.3 % and of the SVM model using SPM data was 90.4 %. CONCLUSION: The predictive models built with ROI data and SPM data from [(123)I]FP-CIT SPECT provide great discrimination accuracy between VP and PD. External validation of these methods is necessary to confirm their applicability across centres.
Asunto(s)
Inteligencia Artificial , Procesamiento de Imagen Asistido por Computador/métodos , Enfermedad de Parkinson Secundaria/diagnóstico por imagen , Enfermedad de Parkinson/diagnóstico por imagen , Radiofármacos , Tomografía Computarizada de Emisión de Fotón Único/métodos , Tropanos , Anciano , Anciano de 80 o más Años , Diagnóstico Diferencial , Femenino , Humanos , MasculinoAsunto(s)
Analgesia Epidural/métodos , Trasplante de Riñón , Dolor Postoperatorio/prevención & control , Anestesia Epidural/métodos , Anestesia General , Terapia Combinada , Contraindicaciones , Femenino , Enfermedad de Hodgkin/complicaciones , Enfermedad de Hodgkin/terapia , Humanos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/cirugía , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/etiología , Pruebas de Función Respiratoria , Adulto JovenRESUMEN
Objectives. To review the perioperative management of patients who had undergone bariatric surgery in our institution during an 8-year period, with the aim of identifying variables that correlated with improved clinical outcomes and changes in perioperative practice. Methods. This was a retrospective observational study of 437 patients who had undergone bariatric surgery from January 2005 to June 2013. Of these patients, 163 had undergone open or laparoscopic biliopancreatic diversion (Group 1), and 274 had been managed according to a Tailored Laparoscopic Approach Program (TLAP) (Group 2). We analyzed major cardiocirculatory, pulmonary, and surgery-related complications, mortality rate, intensive care unit (ICU) admissions, post-anesthetic care unit (PACU) length of stay, and perioperative management standards, throughout the study period. Results. Changes were observed in anesthetic patterns and perioperative care standards during the study period: 25% of patients had combined epidural anesthesia in 2005, compared with none at present; ICU admissions decreased from 28.6% in 2005 to 3.1% at present; and time in PACU declined from a median of 23 h in 2005 to 5.12 h at present. Duration of postoperative opioid therapy was also significantly reduced (from 48 h to 6 h). Group 2 had a significantly lower mortality rate than Group 1 (0.37% versus 4.3%, respectively, P = 0.004). Conclusions. In our institution, adoption of a TLAP for bariatric surgery has led to changes in perioperative care standards that have been followed by clear improvements according to morbidity, mortality and management indicators (AU)
Objetivos. Analizar el tratamiento perioperatorio de los pacientes que hayan sido intervenidos de cirugía bariátrica en nuestro centro durante un período de 8 años de duración, con el objetivo de identificar variables que puedan guardar relación con resultados clínicos mejorados y cambios en la práctica perioperatoria. Metodología. Estudio de observación retrospectivo de 437 pacientes que se sometieron a cirugía bariátrica entre enero de 2005 y junio de 2013. De ellos, 163 fueron intervenidos mediante derivación biliopancreática abierta o laparoscópica (Grupo 1) y 274 fueron tratados conforme al Programa de Abordaje LaparoscópicoPersonalizado (Grupo 2). Analizamos las principales complicaciones cardiovasculares, pulmonares y quirúrgicas, la tasa de mortalidad, los ingresos en UCI, el tiempo en la Unidad de Reanimación y las pautas del tratamiento perioperatorio durante el período del estudio. Resultados. Apreciamos cambios en los patrones de anestesia y las pautas de tratamiento perioperatorio durante el período del estudio: un 25% de los pacientes combinaron la anestesia epidural en 2005 en comparación con ninguno en la actualidad; los ingresos en la UCI disminuyeron del 28,6% en 2005 al 3,1% en la actualidad; y la estancia en la Unidad de Reanimación se redujo en una mediana de 23 h en 2005 a 5,12 h en la actualidad. La duración del tratamiento perioperatorio con opiodes también se acortó de manera significativa (de 48 a 6 h). El Grupo 2 presentó una tasa de mortalidad considerablemente más baja que el Grupo 1 (0,37 frente a 4,3%, respectivamente; p = 0,004). Conclusiones. En nuestro centro, la implantación del Programa de Abordaje Laparoscópico Personalizado para la cirugía bariátrica ha fraguado cambios en las pautas de tratamiento perioperatorio que han supuesto mejoras evidentes en lo que a morbimorbilidad e indicadores de gestión se refiere (AU)
Asunto(s)
Humanos , Masculino , Femenino , Cirugía Bariátrica/instrumentación , Cirugía Bariátrica/métodos , Cirugía Bariátrica/tendencias , Anestesia/métodos , Anestesia , Hospitalización/economía , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Tiempo de Internación/tendencias , Cirugía Bariátrica/normas , Cirugía Bariátrica , Medicina Bariátrica/tendencias , Periodo Perioperatorio/métodos , Periodo Perioperatorio/tendencias , Anestesia/normas , Anestesia/tendencias , Laparoscopía/tendencias , Laparoscopía , Indicadores de MorbimortalidadRESUMEN
La oftalmopatía tiroidea es una rara complicación extratiroidea normalmente asociada a la enfermedad de Graves. Esta afección puede ocurrir en pacientes embarazadas eutiroideas. La orbitopatía de Graves se caracteriza por retracción palpebral, proptosis, disfunción de los músculos extraoculares y edema periorbitario. En algunos casos puede ser requerida una intervención quirúrgica urgente para evitar la pérdida irreversible de la visión. Presentamos un caso de una mujer de 35 años en la semana 30 de gestación con oftalmopatía de Graves, severo exoftalmos y reducción de la agudeza visual. Tras las consultas realizadas entre anestesiólogos, oftalmólogos, cirujanos maxilofaciales, endocrinólogos, obstetras y la paciente se decidió un abordaje quirúrgico para descompresión orbitaria. Describimos un caso con diversas implicaciones anestésicas y perioperatorias en función de la edad gestacional de la paciente y las consideraciones para este procedimiento quirúrgico, y para evitar el aumento de la presión intraocular (AU)
Thyroid ophthalmopathy is a rare extra-thyroid complication usually associated with Graves disease. This disease can occur in the euthyroid pregnant patient. Graves orbitopathy is characterized by eyelid retraction, proptosis, extraocular muscle dysfunction, and periorbital edema. In some cases an emergency surgical repair may be required to avoid irreversible vision loss. We present the case of a 35-year-old woman in her 30th gestational week, who suffered from Graves ophthalmopathy, severe exophthalmia, and visual acuity decrease. Following consultations among anesthesiologists, ophthalmologists, maxillofacial surgeons, endocrinologists, obstetricians and the patient, it was decided to perform a surgical orbital wall decompression. The anesthetic and perioperative implications associated with gestational age and the considerations for this surgical procedure, and how to avoid increasing intraocular pressure are discussed